[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001267879A1 - Acylsulfonamide derivatives - Google Patents

Acylsulfonamide derivatives

Info

Publication number
AU2001267879A1
AU2001267879A1 AU2001267879A AU6787901A AU2001267879A1 AU 2001267879 A1 AU2001267879 A1 AU 2001267879A1 AU 2001267879 A AU2001267879 A AU 2001267879A AU 6787901 A AU6787901 A AU 6787901A AU 2001267879 A1 AU2001267879 A1 AU 2001267879A1
Authority
AU
Australia
Prior art keywords
acylsulfonamide derivatives
acylsulfonamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267879A
Other languages
English (en)
Inventor
Hiroshi Ikawa
Kazuhiro Kojima
Hideki Kosono
Takashi Nakamura
Masato Nishimura
Keiji Okada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2001267879A1 publication Critical patent/AU2001267879A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001267879A 2000-07-05 2001-06-29 Acylsulfonamide derivatives Abandoned AU2001267879A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000204002 2000-07-05
JP2000-204002 2000-07-05
PCT/JP2001/005626 WO2002002517A1 (fr) 2000-07-05 2001-06-29 Derives d'acylsulfonamides

Publications (1)

Publication Number Publication Date
AU2001267879A1 true AU2001267879A1 (en) 2002-01-14

Family

ID=18701334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267879A Abandoned AU2001267879A1 (en) 2000-07-05 2001-06-29 Acylsulfonamide derivatives

Country Status (4)

Country Link
US (1) US6812252B2 (fr)
EP (1) EP1316548A4 (fr)
AU (1) AU2001267879A1 (fr)
WO (1) WO2002002517A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393652B2 (en) 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
JP2005194191A (ja) * 2001-12-28 2005-07-21 Ajinomoto Co Inc 抗肥満薬、脂肪肝治療薬
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7167106B2 (en) * 2004-04-15 2007-01-23 3M Innovative Properties Company Methods and systems utilizing a programmable sign display located in proximity to a traffic light
JPWO2005108370A1 (ja) * 2004-04-16 2008-03-21 味の素株式会社 ベンゼン化合物
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555584B1 (en) 2000-06-29 2003-04-29 Ajinomoto Co., Inc. Acylsulfonamide derivative
JPH11171856A (ja) * 1997-09-26 1999-06-29 Fujirebio Inc アシルスルホンアミド誘導体
JPH11171848A (ja) * 1997-09-26 1999-06-29 Fujirebio Inc 芳香族アミド誘導体
JPH11222437A (ja) * 1998-02-04 1999-08-17 Tokiwa Yakuhin Kogyo Kk カキ由来粉末を含むniddm治療用の医薬組成物および健康食品
JP2000038350A (ja) * 1998-05-18 2000-02-08 Yoshitomi Pharmaceut Ind Ltd 糖尿病治療薬
JP2001048794A (ja) * 1999-08-09 2001-02-20 Tokiwa Yakuhin Kogyo Kk 桑の葉由来粉末およびカキ由来粉末の混合物を含むniddm治療用の医薬組成物および健康食品
JP2001199888A (ja) * 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
WO2002002101A1 (fr) 2000-07-05 2002-01-10 Ajinomoto Co., Inc. Composes hypoglycemiques

Also Published As

Publication number Publication date
EP1316548A1 (fr) 2003-06-04
US6812252B2 (en) 2004-11-02
US20030181764A1 (en) 2003-09-25
EP1316548A4 (fr) 2004-05-19
WO2002002517A1 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001293852A1 (en) Sulfonylguanidine
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001267879A1 (en) Acylsulfonamide derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001246864A1 (en) Hypotensors
AU7447500A (en) Acylsulfonamide derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2001226668A1 (en) Crankshaft-starter-generator